Details of the Drug

General Information of Drug (ID: DMSJ54W)

Drug Name
PC14586
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Drug Type
Small interfering RNA
Cross-matching ID
TTD ID
D53CGK

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
P53 Y220C mutant (TP53 Y220C) TTJC50M P53_HUMAN Reactivator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04585750) The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of PMV Pharmaceuticals.